Ripon College working with Eli Lilly to screen molecules for potential pharmaceutical use
Ripon College now is affiliated with the Open Innovation Drug Discovery Program at Eli Lilly. Through this program, students and faculty will use the technology at Eli Lilly to virtually screen molecules for their potential to be pharmaceuticals. After virtual screening, students and faculty will send molecules prepared at Ripon College to Eli Lilly for actual biological testing.
This program allows students and faculty to use their research to directly participate in the discovery of new pharmaceuticals. For example, several students in Assistant Professor of Chemistry Patrick Willoughby’s research lab have synthesized many completely new molecules. These molecules now can be assessed for their viability to treat disease and other ailments.
“I am excited to see student research at Ripon College directly contribute to the discovery of new drugs,” Willoughby says. “This undoubtedly will enhance their understanding of modern medicine and positively affect the prospect of them pursuing a career in health sciences.”
Related Posts
Kaleb Schroeder to perform senior vocal recital Nov. 23
Kaleb Schroeder of Iron Ridge, Wisconsin, is performing his senior tenor vocal recital in the Benstead Theatre of the C.J. Rodman Center for the Arts […]
Ripon College Ethics Bowl team competes at regional competition
Six students from the Ripon College Ethics Bowl team competed in the Upper Midwest Regional Ethics Bowl Nov. 16 at the University of Chicago. The […]
Ripon biology students win awards for research at WiSER conference
Ripon College’s biology senior seminar students took home awards for their research at the inaugural WiSER conference in early October. WiSER is a consortium of […]
Ripon College’s theatre department to present “The Thin Place” Nov. 6-9
RIPON, Wisconsin – Ripon College’s theatre department is putting on the play “The Thin Place” by Lucas Hnath in the Benstead Theatre in the C.J. […]
